Hyaluronic acid-based prodrug nanomedicines for enhanced tumor targeting and therapy: A review
R Zhang, X Zhao, A Jia, C Wang, H Jiang - International Journal of …, 2023 - Elsevier
Hyaluronic acid (HA) represents a natural polysaccharide which has attracted significant
attention owing to its improved tumor targeting capacity, enzyme degradation capacity, and …
attention owing to its improved tumor targeting capacity, enzyme degradation capacity, and …
Recent progresses in the development of hyaluronic acid-based nanosystems for tumor-targeted drug delivery and cancer imaging
HJ Cho - Journal of pharmaceutical investigation, 2020 - Springer
Background Hyaluronic acid (HA) has been widely used as one of major components of
nanocarriers for cancer imaging and therapy. HA possesses hydrophilic and anionic …
nanocarriers for cancer imaging and therapy. HA possesses hydrophilic and anionic …
[HTML][HTML] Development and application of hyaluronic acid in tumor targeting drug delivery
Z Luo, Y Dai, H Gao - Acta Pharmaceutica Sinica B, 2019 - Elsevier
Hyaluronic acid (HA) is a natural polysaccharide that has gained much attention due to its
biocompatibility, enzyme degradation capacity and active tumor targeting capacity. Its …
biocompatibility, enzyme degradation capacity and active tumor targeting capacity. Its …
A potential carrier for anti-tumor targeted delivery-hyaluronic acid nanoparticles
J Cai, J Fu, R Li, F Zhang, G Ling, P Zhang - Carbohydrate polymers, 2019 - Elsevier
In recent years, biomacromolecules have been widely used in anti-tumor delivery systems
due to the biocompatibility and biodegradability. However, their applications are limited due …
due to the biocompatibility and biodegradability. However, their applications are limited due …
Advances in hyaluronic acid-based drug delivery systems
Y Jiao, X Pang, G Zhai - Current Drug Targets, 2016 - ingentaconnect.com
Hyaluronic acid (HA) is a relatively new polymer for the construction of drug delivery
systems. CD44 and the receptor for HA-mediated motility play a key role in vivo for the …
systems. CD44 and the receptor for HA-mediated motility play a key role in vivo for the …
[HTML][HTML] Hyaluronic acid-coated nanomedicine for targeted cancer therapy
Hyaluronic acid (HA) has been widely investigated in cancer therapy due to its excellent
characteristics. HA, which is a linear anionic polymer, has biocompatibility, biodegradability …
characteristics. HA, which is a linear anionic polymer, has biocompatibility, biodegradability …
Recent advances in hyaluronic acid-based nanomedicines: Preparation and application in cancer therapy
Rapid development of stimuli-responsive drug delivery systems (DDSs) for tumor therapy
has raised increasing interest in recent decades, and many nanomedicines are prepared to …
has raised increasing interest in recent decades, and many nanomedicines are prepared to …
Development and mechanistic insight into enhanced cytotoxic potential of hyaluronic acid conjugated nanoparticles in CD44 overexpressing cancer cells
The overexpression of CD44 in cancer cells reroutes number of oncogenic pathways
including the central Pi3K/Akt/NF-kB pathway leading to cancer progression and …
including the central Pi3K/Akt/NF-kB pathway leading to cancer progression and …
Recent developments in hyaluronic acid-based nanomedicine for targeted cancer treatment
Introduction: Hyaluronic acid (HA) has emerged as a promising applicant for the tumor-
targeted delivery of various therapeutic agents. Because of its biocompatibility …
targeted delivery of various therapeutic agents. Because of its biocompatibility …
[HTML][HTML] Hyaluronic acid-based nanocarriers for anticancer drug delivery
CP Fu, XY Cai, SL Chen, HW Yu, Y Fang, XC Feng… - Polymers, 2023 - mdpi.com
Hyaluronic acid (HA), a main component of the extracellular matrix, is widely utilized to
deliver anticancer drugs due to its biocompatibility, biodegradability, non-toxicity, non …
deliver anticancer drugs due to its biocompatibility, biodegradability, non-toxicity, non …